PhD Student Position: The Role of an Epstein-Barr Virus Infection in the Development of Multiple Sclerosis
Reference number: 2024-0318
- Heidelberg
- Vollzeit
- Pathogenesis of Virus Associated Tumors
“Research for a life without cancer" is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.
The Division of Pathogenesis of Virus Associated Tumors is offering a
The Epstein-Barr virus (EBV) causes multiple types of malignant tumors in humans. However, a recent large epidemiological study has demonstrated that EBV infection also constitutes the strongest single risk factor to date for the development of multiple sclerosis (MS) (Bjornevik et al., Science, 2022). MS is the most frequent demyelinating disease, mainly affects young adults and leads to progressive neurodegeneration and disability. How EBV is involved in the pathogenesis of MS, remains disputed.
Our research group coordinates a joint international research effort, the BEHIND-MS consortium, that is funded by HORIZON Europe and consists of ten multidisciplinary research groups from various EU countries. PhD candidates will benefit from interactions with the vibrant research community involved in the BEHIND-MS consortium and at the DKFZ. The DKFZ has state-of-the-art core facilities in all areas of biology, including genomics, proteomics, imaging and immunology.
Your Tasks
The project will involve characterization of interactions between the virus, the immune system and the central nervous system. Methodological approaches include manipulation of infected cells, reprogrammed neural cells, and the immune system, particularly T cells specific for viral antigens. Our group collaborates with the “Chronically progressive neurodegenerative diseases" research group (PI: Marc Thier) at the DKFZ, that will reprogram immune cells into neural progenitors and derive neural cultures and organoids.
Your Profile
- Master’s degree in biology, medicine, biochemistry or related disciplines
- Previous experience in common molecular and cellular biology techniques,
competence in bioinformatics is an asset - Excellent command of written and oral English, with a proof of language proficiency (IELTS >6.5 or TOEFL>90)
A proof of language proficiency is not required for those coming from German-speaking countries (Germany, Austria, Switzerland), as well as native English speakers from Australia, Canada, Ireland, UK and USA. - Ability to work independently and as part of a team
Applications should include contact details of two referees.
We Offer
Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
Access to international research networks
Doctoral salary with the usual social benefits
30 days of vacation per year
Flexible working hours
Possibility of part-time work
Family-friendly working environment
Sustainable travel to work: subsidized Germany job ticket
Unleash your full potential: targeted training and mentoring through the DKFZ International PhD Program and DKFZ Career Service
Our Corporate Health Management Program offers a holistic approach to your well-being
Are you interested?
Then become part of the DKFZ and join us in contributing to a life without cancer!
Prof. Dr. Henri-Jacques Delecluse
Phone: +49 (0)6221/42-4870
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.